Cadence Pharma recalls one lot of Ofirmev
(Reuters) - Cadence Pharmaceuticals Inc said it recalled one lot of its injectable painkiller Ofirmev after a routine stability test revealed the presence of an unidentified particle in a vial. (Source: Reuters: Health)
Research partnership to improve treatments for cancer patients
(Walter and Eliza Hall Institute) The Australian Cancer Research Foundation has committed $2 million towards the fit-out of two new cancer research laboratories at the Walter and Eliza Hall Institute. (Source: EurekAlert! - Medicine and Health)